Poster: AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)

Authors :: Amer M. Zeidan
Jörg Westermann
Tibor Kovacsovics
Sarit Assouline
Andre C. Schuh
Hee-Je Kim
Gabriela Rodriguez Macias
David Sanford
Marlise R. Luskin
Eytan M. Stein
Kamel Malek
Jiaying Lyu
Mario Stegert
Jordi Esteve
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S125
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools